Patrick Soon-Shiong is an individual angel investor who leverages his background as a surgeon and pharmaceutical. See sector focus and contact routes.
Patrick Soon-Shiong is an individual angel investor who leverages his background as a surgeon and pharmaceutical entrepreneur, having built his wealth by founding and selling two drug companies for approximately $8 billion before expanding into a broad ecosystem under NantWorks. His investment thesis centers on healthcare, drug discovery, and technology, with a focus on using data and genetic information to pioneer treatments for cancer and other diseases. As an angel investor, he typically invests personal money into promising companies in exchange for equity, with his latest known investment occurring in October 2024 in Alyssum Therapeutics, a drug discovery firm. While specific check sizes and lead/follow behavior are not publicly detailed in available records, his portfolio includes nine total investments, suggesting a selective approach to early-stage opportunities. Notable portfolio companies include Alyssum Therapeutics, NantHealth (which he took public), and ImmunityBio, where he serves as Executive Chairman. Soon-Shiong distinguishes himself through a distinctive point of view that integrates medical science with AI and data transport, holding over
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Los Angeles.
Investors like Patrick Soon-Shiong · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide